Workflow
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection
ZACKS· 2026-01-07 02:36
Key Takeaways Ceribell received FDA Breakthrough Device Designation for its AI-based LVO stroke detection solution.CBLL is extending its point-of-care EEG platform beyond seizures and delirium into time-sensitive stroke care.The designation supports faster FDA interactions and earlier commercialization, boosting CBLL's visibility.CeriBell Inc. (CBLL) recently announced that the FDA has granted Breakthrough Device Designation for its Large Vessel Occlusion (LVO) stroke detection and monitoring solution desig ...
Strength Seen in Kulicke and Soffa (KLIC): Can Its 6.2% Jump Turn into More Strength?
ZACKS· 2026-01-07 02:36
Kulicke and Soffa (KLIC) shares rallied 6.2% in the last trading session to close at $51.33. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 0.3% loss over the past four weeks.Kulicke and Soffa is benefiting from improved order activity, favorable utilization trends in semiconductor and memory markets, and growth in advanced packaging, advanced dispense, and power semiconductor opportunities.This semiconducto ...
Fifth Third Shareholders and Comerica Stockholders Vote to Approve Combination
Businesswire· 2026-01-07 02:32
CINCINNATI & DALLAS--(BUSINESS WIRE)--Today, shareholders of Fifth Third Bancorp (Nasdaq: FITB) and stockholders of Comerica Incorporated (NYSE: CMA) voted separately to approve the proposed merger of the two companies. The transaction is expected to close in the first quarter of 2026, subject to satisfaction of the remaining customary closing conditions. "Today's favorable shareholder vote with 99.7% of votes cast in favor of our combination with Comerica marks an important milestone in our jo. ...
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall Survival Benefit
Prnewswire· 2026-01-07 02:32
Positive Phase 3 HERIZON-GEA-01 results support Ziihera as the HER2-targeted agent-of-choice in HER2+ first-line metastatic GEA and Ziihera plus chemotherapy to replace trastuzumab as the new standard of care, with or without tislelizumab regardless of PD-L1 status Late-breaking results to be presented at the 2026 ASCO Gastrointestinal Cancers Symposium (ASCO GI) on January 8, 2026 For U.S. media and investors only ® ® DUBLIN, Jan. 6, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announ ...
Strong Performance & Income From a Unique High Yield ETF
Etftrends· 2026-01-07 02:31
In terms of sheer size, DWS may not compete with the Vanguards and BlackRocks in the ETF space when it comes to garnering the most market share. However, it does something to discern itself from the m... ...
Gold and Silver at All-Time Highs: Investors Converge in Vancouver for the Resource Event That Matters
TMX Newsfile· 2026-01-07 02:30
Vancouver, British Columbia--(Newsfile Corp. - January 6, 2026) - With gold, silver and copper trading at all-time highs and capital flooding back into hard assets, the resource investment market is experiencing its strongest momentum in years. At the center of it all: the Vancouver Resource Investment Conference (VRIC) 2026, returning to the Vancouver Convention Centre West on January 25-26, 2026.Produced by VRIC Media, VRIC is the world's largest and most influential gathering for junior mining and resou ...
January Rally Continues as Precious Metals Rise and Rates Move Higher
Investing· 2026-01-07 02:30
股市整体表现 - 年初至今(YTD)股市持续反弹,罗素2000指数领涨,涨幅为+2.4%,道琼斯指数上涨2.3%,标普500指数上涨0.6%,等权重标普500指数上涨1.9%,纳斯达克指数持平,而“科技七巨头”组合下跌1.1% [1] - 过去12个月(LTM)纳斯达克指数表现超越“科技七巨头”,涨幅分别为+18.1%和+16.1% [1] - 当日盘中涨势有所消退,道指仍上涨0.4%,等权重标普500指数上涨0.7%,纳斯达克指数几乎持平,而“科技七巨头”下跌0.6% [5] 行业板块表现 - 过去12个月(LTM)表现最强的板块是科技(+24.4%)、工业(+20.3%)和通信服务(+20.3%)[2] - 过去12个月(LTM)表现较弱的板块包括非必需消费品(+6.9%)、能源(+5.4%)、房地产(+0.2%),必需消费品是唯一下跌的板块,跌幅为-0.9% [2] - 半导体行业过去12个月(LTM)表现强劲,涨幅高达+48.4% [1] 个股与特定板块动态 - 英伟达(NVIDIA)过去12个月(LTM)股价上涨27.1% [1] - 在“科技七巨头”中,当日仅亚马逊(AMZN)和英伟达(NVDA)股价上涨 [5] - 半导体板块当日上涨2.6%,部分得益于在拉斯维加斯举行的国际消费电子展(CES)[5] 大宗商品与加密货币表现 - 黄金价格一度突破每盎司4500美元,随后小幅回落 [4] - 白银价格突破每盎司80美元,当日再涨4.5%,据报道亚洲实物价格显著更高 [4] - 铜价创下每盎司6美元以上的新高,一个月内上涨11% [4] - 铂金价格上涨5.6%,接近历史高点 [4] - 比特币价格达到93.3K美元,一周内上涨5.1%,此前曾触及94.4K美元 [4] - 原油价格持稳于每桶58美元,汽油价格持平,而天然气价格下跌3.8%至每百万立方英尺3.40美元以下,一个月内跌幅超过33% [4] 利率与汇率 - 美国利率再次上升,2年期国债收益率上升超过2个基点至3.48%,10年期国债收益率上升2个基点至4.19% [3] - 日本10年期国债收益率创下2.13%以上的新高 [3] - 美元指数小幅上涨至98.3,但仍远低于12月初高于99的水平 [3]
ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA
Businesswire· 2026-01-07 02:30
SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with and without PD-1 inhibitor TEVIMBRA® (tislelizumab), as a first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). These data, inclu ...
Trane Technologies Shares Slip 4%
RTTNews· 2026-01-07 02:29
Trane Technologies plc (TT) shares fell 4.22 percent on Tuesday, declining $16.51 to $374.46, with no company-specific news reported to explain the move.The stock was last trading at $374.46, compared with a previous close of $390.97. Shares opened higher at $395.30 before selling pressure pushed the stock to a day's low of $348.06 on the New York Stock Exchange. Trading volume reached about 2.56 million shares, above the stock's average daily volume of roughly 1.23 million shares.Trane Technologies has tr ...
Brazil's Petrobras pauses Foz do Amazonas drilling after fluid leak
Reuters· 2026-01-07 02:29
A fluid leak has halted Brazilian state-run oil firm Petrobras' drilling of a well in the environmentally sensitive Foz do Amazonas Basin, the company said on Tuesday. ...